The third batch of national organizations high -value medical consumables collective scanning: an average price reduction 84% is expected to save 26 billion yuan

The third batch of national organizations high -value medical consumables will be held on the 27th and the results of the selection are generated. Focusing on orthopedic spine consumables, the average price reduction price reduction in the collection is 84%, and it is expected to save 26 billion yuan per year. In the first year, the purchase volume was 1.09 million units, accounting for 90%of the total demand for medical institutions in the country.

Following the coronary bracket and orthopedic arthropate joints, the "national team" once again aimed at the "hard task" of high -value medical consumables. What are the highlights of this collection? When can patients be used? The reporter interviewed.

According to Gao Xue, the leader of the National Organization of High -value Medical consumables joint procurement team, from Gao Xue, from the perspective of historical data collection, in 2021, various spine surgery across the country was about 1.2 million units, and the sales amount of spine consumables was nearly 35 billion yuan, accounting for accounting The total amount of all high -value medical consumables exceeds 15%, and the environment for bidding has formed.

"6,426 medical institutions in the country reported to the purchase demand of 1.2 million units, and a total of 171 companies participated in the collection." Gao Xue introduced that this collection scope covers more than 90%of the spine consumable products in the market, which fully meets the clinical clinical clinical. Treatment needs.

In terms of price, the average price reduction of the orthopedic spine consumables was 84%. Because orthopedic surgery requires enterprises to provide clinical follow -up services such as clinical and Taiwan, this time the collection still adopts a single -column with service costs to ensure the stable supply and use of the product.

"Orthopedic spine consumables collection is an important measure to treat orthopedic medical consumables and chaos." Gao Xue said that this will help purify the industry's ecology, promote the standardized and rational use of high -value medical consumables, and effectively reduce the masses Cosmetic burden.

According to the type of surgical type and surgical site, the product system is divided into 14 product system categories such as the orthopedic spine consumables into 14 product systems such as the cervical spine nail plate fixed fusion system.

"In terms of product characteristics, the spine system is relatively complicated." Zhang Jie, an expert in the joint procurement office of the National Organization of High -value Medical Consumption, said that in order to achieve the full coverage of the spine products, the collection of scientific grouping this time was divided into 29. A total of 29 was divided into 29 The bidding unit.

In addition, in order to fully respect the clinical choices, this collection is self -reported and self -selected products by medical institutions to meet clinical needs and achieve "use for use".

"The consumables have done a lot of basic work in the early stage to ensure the effectiveness and reasonable reporting volume, so that enterprises can better participate in it." Lu Yun, a professor at the International Medical Business School of China University of Pharmacy, introduced that enterprises can fully consider themselves according to the amount of reporting. The production capacity of the product properly arranges the supply and distribution and accompanying services.

Different from the first two batches of high -value medical consumables collection, the purchase cycle of orthopedic spine consumables is 3 years. The actual implementation date of the results of the alliance in various regions of the alliance is calculated. Perform from the month.

"The expansion of this collection of procurement cycle has stabilized market expectations and can be more convenient for enterprises to arrange production plans." Zhang Jie said that at the same time, it can also achieve the continuity of clinical products and ensure clinical treatment and follow -up services.

This time the collection of bidding rules innovated, increased the two "resurrection mechanisms" between the bidding unit and the maximum and effective declaration price, and promoted more Multi -enterprises are selected to enhance the expected stability.

According to reports, patients are expected to use the selected products after the collection of price reductions in February 2023.

(Editor in charge: Wang Qingyu)

- END -